Oyster Point Pharma, Inc. Credit Agreements

1 Contracts & Agreements

Recent Contracts

Waiver and Amendment, dated as of October 19, 2021, by and among Oyster Point Pharma, Inc., OrbiMed Royalty & Credit Opportunities III, LP. and the other parties thereto (Filed With SEC on October 19, 2021)